
Senior Mobile App Engineer (React Native)
Beacon Biosignals2 hours ago
Base Salary
$150k - $170k/yr
Responsibilities
- Develop React Native mobile applications and native iOS and Android BLE device SDKs.
- Design and implement user workflows for clinical trial participants and at-home diagnostic patients.
- Own app and feature user experience, performance, reliability, and observability.
- Improve BLE pairing and reconnection reliability across iOS and Android.
- Partner with Devices, Platform, product design, and Clinical Operations teams to deliver integrated mobile capabilities.
- Help shape the roadmap and technical direction of the mobile platform.
Requirements
- 5+ years of experience in mobile development using native iOS/Android and/or React Native.
- Experience with BLE, sensor integration, or health data streams.
- Familiarity with TypeScript, React Native, Swift, Kotlin, Expo, and GitHub.
- Strong product and UX mindset with attention to edge cases and performance.
- Strong communication skills and comfort working in a collaborative asynchronous environment.
- Experience with medical devices, EEG, wearables, clinical trials, patients, regulated environments, or open-source mobile/BLE projects is preferred.
- Extensive native development experience for iOS or Android in addition to React Native is preferred.
Benefits
- Remote work is supported through asynchronous work practices, with in-person office hubs in Boston and New York.
- Candidates may be based anywhere in the US Eastern time zone.
- Total compensation includes equity, PTO, and other benefits.
Tech Stack
Categories
Mobile
About Beacon Biosignals
Beacon Biosignals builds an AI platform and FDA-cleared at-home EEG wearables used by biopharma and clinicians to develop and deliver treatments for neurological, psychiatric, and sleep disorders. It sells clinical development services and software for brain-signal analysis to life sciences partners, and operates a diagnostics business providing reimbursable EEG and cardiopulmonary assessments. Founded in 2019 and headquartered in Boston, the company is privately held.